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INTRODUCTION 
Retinitis pigmentosa (RP) is a diffuse 
retinal dystrophy predominantly affecting the 
rod system more than cones. [1] It occurs in 
5/1000 persons of the world population. [2] At 
the beginning, there is degeneration of the 
rods and cones along with the pigment 
epithelium and migration of the pigment into 
the retina mainly around the blood vessels. 
Later on, the ganglion cells and their axons 
also degenerate and they are replaced by 
neuroglial tissue. The blood vessels become 
attenuated and the disc assumes a waxy 
yellow appearance and is often termed as 
‘consecutive optic atrophy’.[3] Many 
experiments have been conducted and still 
going on in the management to improve the 
vision in dim light and arrest the further 
progression, but promising result is yet to be 
found.  
Visual symptoms of retinitis 
pigmentosa include night blindness, impaired 
dark adaptation and tubular vision. In most 
cases, patients show an early night blindness 
and loss of peripheral field of vision, but 
central vision is generally preserved until the 
late stages of the disease. The classic clinical 
triad of retinitis pigmentosa are (a) arteriolar 
attenuation (b) retinal bone spicule 
pigmentation and (c) waxy disc pallor. [4] 
Retinitis pigmentosa (RP) is a hereditary group of degenerative eye diseases caused by 
genetic mutations affecting retina that lead to severe vision loss and blindness. In Ayurveda, 
the conditions like Kapha vidagdha drushti, Hraswajadya and Dhoomadarshi which has night 
blindness as the cardinal feature can be simulated to different stages of RP. Certain 
authenticated therapies are explained in our ancient literature which are time tested such as 
Tarpana(Nourishing eye bath therapy), Putapaka (eye bath therapy), Anjana (Collyrium), 
Nasya (Processed liquid instillation through nostrils by drops or powders), Sirodhara 
(application of continuous stream of oil over the head), Vasti (Medicated enema) etc. 
through which considerable results are achieved. The drugs and procedures described in 
Ayurveda have probable mode of action in crossing the blood retinal barrier, a protective 
measure of cells surrounding the retina. The extent of benefit in alleviating the clinical 
features of RP happens possibly because of the phytonutrients present in the formulations 
applied through various procedures crossing the blood retinal barrier. To validate the 
management protocol explained in classics, a retrospective study was conducted on five 
patients selected from the OPD/IPD of Dept of Shalakya Tantra of Sri 
Kalabyraveshwaraswamy Ayurvedic Medical College, Hospital & Research centre, 
Vijayanagar(SKAMC,H & RC). The results assessed statistically proved significant in certain 
parameters indicating a beneficial effect in reducing the subjective symptoms of Retinitis 
pigmentosa.  
KEYWORDS: Retinitis pigmentosa, Rod, Cone, Kaphavidagdha drushti, Hraswa jadya, 
Dhoomadarshi, Ayurvedic management. 
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There may be other ocular and systemic 
associations also. The ocular associations are 
namely myopia, primary open angle glaucoma, 
microphthalmos, keratoconus, vitreous 
changes and subcapsular cataract. The 
systemic associations include obesity, mental 
deficiency, dwarfism, ataxia, deafness etc. [5]  
The types of RP based on inheritance 
are autosomal recessive (16%), autosomal 
dominant (22%), X-linked (9%) and other are 
isolated (without any family history-
common).[6] In general, the long term 
prognosis of retinitis pigmentosa is poor, with 
eventual loss of central vision due to direct 
involvement of the fovea.[7]  
It usually appears in the childhood and 
progresses slowly, often resulting in blindness 
in advanced middle age. As per existing 
available data, no effective approach for 
prevention, stabilization or reversal is there 
for the majority of RP cases apart from daily 
administration of Vitamin A. [8]  
 In Susruta Samhitha, one of the oldest 
text books of Ayurveda has described 
seventysix Netra (eye) diseases[9] and their 
detailed treatment comprising of both 
medicinal and surgical methods. Among these, 
diseases like Kaphavidagdha drushti, 
Hraswajadya and Dhoomadarshi[10] which 
closely resemble RP in their symptamatology 
and different stages. There is a special mention 
of Kriyakalpas (Ocular therapeutics), designed 
to improve the visual functionalities and 
treating the diseases of eye. Ayurveda rely its 
treatment efficacy on the basis of Tridosha 
(roughly translated as three humors) and the 
drugs used in eye diseases are mainly 
Chakshushya, Drishti prasadaka, Pitta rechaka 
which helps to tackle the condition of RP and 
reduce the symptoms to a greater extent and 
these Kriya kalpas are based on Dosha 
afflicting and condition of the disease. 
Aims & Objectives 
 To compile various suitable therapies 
available in Ayurveda for retinitis 
pigmentosa. 
 To evaluate the efficacy of suitable 
therapies for Retinitis pigmentosa. 
 
 
Materials & Methods 
A) Study design 
Patients attending the OPD and IPD of 
PG Dept of Shalakyatantra of SKAMC H & RC 
Bangalore with history of clinical signs & 
symptoms of Retinitis pigmentosa (RP), were 
screened as per the inclusion & exclusion 
criteria and accordingly registered for this 
study. All the details about the disease 
conditions and various suitable therapies for 
Retinitis pigmentosa before and after the 
treatment were recorded in case proforma as 
per the protocol.  
Diagnosis 
 The diagnosis of the disease is done on 
both modern and Ayurvedic basis, from the 
symptoms and ocular examination.  
 Routine blood investigations, fasting blood 
sugar, serum cholesterol and routine urine 
investigations were done to rule out any 
systemic diseases. 
Medicaments Used 
The medicaments used in managing the 
condition are Mahatriphaladya ghrita, 
Jeevantyadi ghrita, Ksheerabala taila, 
Mahamasha taila, Saptamruta loha, Tapyadi 
loha, Vasaguduchyadi kashaya, Chakshushya 
kashaya vasti, Kanadi anjana- Kanadi putapaka 
and Avipattikara churna 
Purchased Medicines 
 Jeevantyadi ghrita, Mahatriphaladya ghrita, 
Avipattikara choorna (Pentacare company) 
 Saptamruta loha, Tapyadi Loha 
(Dhoodhpapeswar company) 
 Ksheerabala taila, Mahamasha taila & 
Vasaguduchyadi kasaya (Arya Vaidyasala 
Kottakkal) 
Prepared medicines 
 Kanadi putapaka, Kanadi anjana are 
prepared in Kriyakalpa section of Dpt. of 
Shalakyatantra SKAMCH & RC, Bangalore. 
 Vasti dravya is made ready in 
Panchakarma section of SKAMCH & RC, 
Bangalore. 
Initially after the patient has been 
enrolled for study, they have to undergo 
Snehana, Swedana for three days, followed by 
Virechana one day as Sodhana karma, this is 
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followed by Chakshushya kasaya vasti for three 
days. After that, first three patients were 
administered by Jeevantyadi ghrita (30days) 
orally, and rest two patients on 
Mahatriphaladya ghrita (30 days). Later all 
five patients to follow the Shamana ausaodhis 
as mentioned in the table from 15 to 30 days 
depending on the clinical diagnosis based on 
the pre-defined protocol as mentioned in the 
table no-1. After that Kriyakalpas are to be 
started in an order Anjana, Tarpana and 
Putapaka. After a week gap, Moordha taila to 
be given as Shirodhara for each patient for 
7days. After that, the patients will be kept 
under follow up after a month.  
 Table 1: Procedures and Medicaments used in the Retinitis pigmentosa
Procedures & Medicaments Patient1 Patient2 Patient3 Patient4 Patient5 
Shodhana 
Snehana Mahatriphaladya 
ghrita 
3 days 3 days 3 days 3 days 3 days 
Virechana Avipattikara choorna 1 day 1 day 1 day 1 day 1 day 
Vasti Chakshushya kasaya 3 days 3 days 3 days 3 days 3 days 
Shamana 
Jeevantyadi ghrita 
Mahatriphaladya ghrita 
Vasaguduchyadi kashaya 
Saptamrutha Loha 
Tapyadi Loha 
30days 30days 30days  
 30 days 30 days 
15days 15days 15days 15 days 15 days 
30days 30days 30days 30 days 30 days 
30days 30days 30days 30 days 30 days 
Kriyakalpa 
Tarpana Mahatriphaladya 
ghrita 
 7 days 7 days 
Jeevantyadi ghrita 7 days 7 days 7 days  
Putapaka Kanadi yoga 3 days 3 days 3 days 3 days 3 days 
Anjana Kanadi anjana 15 days 15 days 15 days 15 days 15 days 
Moordha Taila 
Shirodhara Ksheerabala taila 7 days 7 days 7 days 7 days 7 days 
Inclusion criteria 
The patients following these criteria 
are considered to be enrolled in the study 
a. The patients of age 10-40 years were 
selected irrespective of sex, occupation, 
religion and socioeconomic status. 
b. Patients clinically diagnosed as retinitis 
pigmentosa. 
Exclusion criteria 
The following criteria have been noted 
for exclusion from the study. 
a. Complete loss of vision 
b. Associated with complicated Cataract, 
Glaucoma, Corneal opacities, Iridocyclitis. 
c. Systemic diseases like Diabetes Mellitus, 
Systemic Hypertension, & hyper cholestremia 
d. Known cases of renal diseases, and any 
Liver disorders 
Assessment criteria 
The Symptomatic changes were 
assessed by using suitable scoring pattern 
ranging from 0-3. 
Observations & Results 
Out of all 5 subjects enrolled for the 
present study have noted with features that 
includes blurred vision, night blindness, 
photophobia, field vision defect, floaters and 
colour blindness. 
No family history was noted for 
retinitis pigmentosa. Among the 5-subjects 
selected, 80% were male, 20% were female. In 
terms of consanguinity, it was present in 40% 
and absent in 60% of subjects; 60% were 
vegetarians and 40% were non-vegetarians; 
60% were Hindu and 40% were Muslim 
(Table No. 2) 
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Table 2: Demographic data 
 Age Group   
Variables 10-15 15-20 20-25 25-30 30-35 35-40 TOTAL % 
SEX 
Male 1 0 1 1 1 0 4 80 
Female 0 0 0 0 0 1 1 20 
CONSANGUINITY 
Present 1 0 0 0 0 1 2 40 
Absent 0 0 1 1 1 0 3 60 
DIET 
Vegetarian 0 0 1 1 0 1 3 60 
Mixed 1 0 0 0 1 0 2 40 
FAMILY 
HISTORY 
0 0 0 0 0 0 0 0 
RELIGION 
Hindu 1 0 1 0 1 0 3 60 
Muslim 0 0 0 1 0 1 2 40 
It has been observed that, the 
symptoms like blurred vision with pre-
treatment mean score 1.8 has been improved 
to mean 1.2. Same way, night blindness which 
usually makes life of a patient miserable has 
been noted to be reduced dramatically from 
the pre to post treatment by almost 50%. 
There were remarked reduction in 
photophobia, and improvement in field of 
vision between pre & post treatment. There 
was marked improvement was noted in 
floaters or spots post treatment. But the 
changes in colour blindness were not 
remarkable. On applying statistical test before 
and after the treatment blurred vision, night 
blindness, photophobia and floaters proved 
highly significant, (p<0.01), Visual field was 
significant p<0.05) and changes in colour 
blindness was insignificant (p>0.05). 
Table-3: Mean of before treatment and after treatment 
S. No. Parameters Before treatment (mean) Before after treatment (mean) 
1 Blurred vision 1.8 1.2 
2 Night blindness 1.6 0.8 
3 Photophobia 1.2 0.4 
4 Field of Vision 1.6 1.2 
5 Spots/Floaters 2.4 1.2 
6 Colour blindness 1.6 1.4 
 
 (Graph-1-Pre & Post treatment) 
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Table 5: Statistical analysis Pre & Post Treatment 
 
DISCUSSION 
a) Jeevantyaadi ghrita[11] 
  Jeevantyaadi ghrita was selected for 
the present study which is specially mentioned 
by Sushruta acharya in Drushtiroga chikitsa. 
The ingredients are Jeevanti (Leptadenia 
reticulata W & A.), Padmaka (Nelumbo nucifera 
Gaertn.), Ashwagandha (Withania somnifera 
(Linn) Dunal., Pippali (Piper longum Linn.), 
Lodhra (Symplocos Racemosus Roxb.), 
Saindhava Lavana, Shatahva (Anethum sowa 
Roxb. Ex Flem.), Madhuyashti (Glycyrrhiza 
glabra Linn.), Draksha (Vitis vinifera Linn.), 
Sita (Cynodon Dactylon Linn), Devadaru 
(Cedrus deodara Roxb. Lowd), Haritaki 
(Terminalia chebula Retz.), Vibhitaki 
(Terminalia bellirica Gaertn. Roxb.), Amalaki 
(Phyllanthus emblica Linn.), Goghrita (Butyrum 
deparatu), Godugdha (Cow milk). This drug 
contains Madhura rasa, Laghu guna, Sheeta 
veerya, Madhura vipaka. 
b) Mahatriphaladya ghrita:[12] 
The major constituents are Haritaki 
(Terminalia chebula Retz.), Vibhitaki 
(Terminalia bellirica Gaertn.Roxb) and 
Amalaki (Phyllanthus emblica Linn) are 
Tridoshahara, Rasayana and Chakshushya. It 
acts as antioxidant and immunomodulator. 
The Goghrita especially having 
Chakshushya, Vrishya, Agnivardhaka, Madhura 
vipaka, Sheeta veerya and Tridoshashamaka 
properties. 
c) Vasaguduchyadi kashaya[13] 
 The major constituents are Vasa 
(Adhatoda vasica Nees), Guduchi (Tinospora 
cordifolia), Nimba (Azadirachta indica), etc. 
which are Pitta-Kapha shamaka and 
Chakshushya. 
d) Saptamruta loha[14] 
 It contains Haritaki (Terminalia 
chebula Retz.), Vibhitaki (Terminalia bellirica 
Gaertn. Roxb.) Amalaki (Phyllanthus emblica 
Linn.) and Loha bhasma (Purified Iron 
powder). Since it is Drushtiprasadaka and 
Rasayana, it is helpful to preserve the eyesight 
and effective in night blindness. 
e)Tapyadi loha[15] 
 Haritaki (Terminalia chebula Retz.), 
Vibhitaki (Terminalia bellirica Gaertn. Roxb.) 
Amalaki (Phyllanthus emblica Linn.), 
Chitrakamoola (Plumbago Zeylanica), Vidanga 
(Emblica Ribes), Mustha (Cyprus Rotundus), 
Darvi (Cedrus Deodar) etc are the ingredients. 
It is Raktapushtikara and indirectly 
Chakshushya. 
f) Kanadi anjana & Kanadi putapaka[16]  
  Both contains Pippali (Piper 
longum Linn.) and goats liver, prepared as per 
Anjana and Putapakakalpana vidhi. 
g) Ksheerabala taila[17] 
  Bala (Sida rhombifolia Linn), milk and 
sesame oil are the ingredients, which is 
Brumhana and pacifies Vata and Pitta. 
h) Mahamasha taila[18] 
  It contains Masha (Phasleolus Mungo), 
Dashamula (a group of ten drugs) etc. It is 
Vatashamaka and give strength to eye through 
Nasya. 
i) Avipattikara choorna[19] 
  It contains Haritaki (Terminalia 
chebula Retz.), Vibhitaki (Terminalia bellirica 
Gaertn. Roxb.) Amalaki (Phyllanthus emblica 
Linn.), Pippali (Pipper longum Linn.), Trivrut 
(Operculina turpethum), Vidanga (Embelica 
ribes) etc. It is Agnivardhaka and Pitta rechaka 
and pacifies Doshas in eye.  
j) Chakshushya vasti[20]  
 Bala (Sida rhombifolia Linn.), Patola 
(Trichosanthes dioica), Eranda (Ricinus 
communis) etc. are the ingredients. The 
Variables Mean SD SE Paired ‘t’ P 
Blurred vision 0.6 0.3 0.1341 4.4742 <0.01 
Night blindness 0.8 0.2 0.0894 8.9485 <0.001 
Photophobia 0.8 0.2 00894 8.9485 <0.001 
Field vision 0.4 0.3 0.1341 2.9828 <0.05 
Spots/Floaters 1.2 0.2 0.0894 13.4228 <0.001 
Colour blindness 0.2 0.2 0.0894 2.2371 <0.10 
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formulation given as Vasti is said as which 
strengthen the eyes. 
CONCLUSION 
The study confirmed that Ayurvedic 
treatment was safe and effective to significant 
extent in reducing subjective symptoms of 
Retinitis pigmentosa thereby improving the 
quality of life of the patients. The drugs and 
procedures used are probably has got a 
rejuvenating action which improve the eye 
structurally and functionally as a whole, 
especially that of retina.  
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